The company claims that Stemcelex naturally stimulates the population of stem cells within the hair follicle. Over 30 years in development, the product is safe and has shown to produce no adverse side effects.
Island Labs has appointed Lorne Meikle as the company’s new chairman. He will direct the global licensing and commercialisation of Stemcelex.
Having served as CEO for nine biotechnology companies, Mr. Meikle is currently president and CEO of Management Dynamics, LOB Ordeins and CEO of Neuroimage. He is also chairman and director of Quest PharmaTech.
Mr. Meikle said: “Stemcelex research indicates that this innovative new product offers significant hair growth improvement over currently marketed products.”